128 related articles for article (PubMed ID: 17462730)
1. What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?
Mele G; Pinna S; Melpignano A; Romano A; Brocca MC; Coppi MR; Quarta G
Leuk Res; 2007 Oct; 31(10):1445-7. PubMed ID: 17462730
[TBL] [Abstract][Full Text] [Related]
2. Isolated central nervous system blast crisis in chronic myeloid leukemia.
Rajappa S; Uppin SG; Raghunadharao D; Rao IS; Surath A
Hematol Oncol; 2004 Dec; 22(4):179-81. PubMed ID: 15995975
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
4. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
[TBL] [Abstract][Full Text] [Related]
5. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
Ottmann OG; Wassmann B; Pfeifer H; Giagounidis A; Stelljes M; Dührsen U; Schmalzing M; Wunderle L; Binckebanck A; Hoelzer D;
Cancer; 2007 May; 109(10):2068-76. PubMed ID: 17429836
[TBL] [Abstract][Full Text] [Related]
6. Isolated central nervous system relapse in acute lymphocytic leukemia (ALL) in children. Experiences of the Swiss Pediatric Oncology Group (SPOG/SAKK) 1976-1986.
Stucki F; Arnet B; Baumgartner C; Beck D; Berchtold W; Bertrand AM; Bleher EA; Caflisch U; Delaleu B; Feldges A
Helv Paediatr Acta; 1988 Nov; 43(3):187-93. PubMed ID: 3065299
[TBL] [Abstract][Full Text] [Related]
7. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
10. Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
Zembutsu H; Yanada M; Hishida A; Katagiri T; Tsuruo T; Sugiura I; Takeuchi J; Usui N; Naoe T; Nakamura Y; Ohno R
Int J Oncol; 2007 Aug; 31(2):313-22. PubMed ID: 17611687
[TBL] [Abstract][Full Text] [Related]
11. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
12. Multiple intracranial tumors in Philadelphia chromosome positive acute lymphoblastic leukemia: successful treatment following aggressive supportive care, early cranial radiation, high dose chemotherapy and imatinib.
Cuvelier GD; Vitali AM; Ford JC; Dix DB
Pediatr Blood Cancer; 2008 Jul; 51(1):135-7. PubMed ID: 18383153
[TBL] [Abstract][Full Text] [Related]
13. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
14. Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study.
Delannoy A; Delabesse E; Lhéritier V; Castaigne S; Rigal-Huguet F; Raffoux E; Garban F; Legrand O; Bologna S; Dubruille V; Turlure P; Reman O; Delain M; Isnard F; Coso D; Raby P; Buzyn A; Caillères S; Darre S; Fohrer C; Sonet A; Bilhou-Nabera C; Béné MC; Dombret H; Berthaud P; Thomas X
Leukemia; 2006 Sep; 20(9):1526-32. PubMed ID: 16838024
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
17. Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
Gupta V; Kamel-Reid S; Minden MD; Lipton JH; Brandwein J; Messner HA
Hematology; 2003 Jun; 8(3):139-43. PubMed ID: 12745646
[TBL] [Abstract][Full Text] [Related]
18. Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Fruehauf S; Topaly J; Buss EC; Schad M; Goerner M; Zeller WJ; Ho AD
Haematologica; 2002 Dec; 87(12):ECR38. PubMed ID: 12495909
[No Abstract] [Full Text] [Related]
19. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
20. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Yanada M; Sugiura I; Takeuchi J; Akiyama H; Maruta A; Ueda Y; Usui N; Yagasaki F; Yujiri T; Takeuchi M; Nishii K; Kimura Y; Miyawaki S; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
Br J Haematol; 2008 Nov; 143(4):503-10. PubMed ID: 18986386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
